🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Doximity executive sells shares worth over $35,000

Published 05/18/2024, 05:38 AM
DOCS
-

SAN FRANCISCO – A recent filing with the Securities and Exchange Commission revealed that Craig Overpeck, Senior Vice President of Commercial Operations at Doximity, Inc. (NYSE:DOCS), sold 1,500 shares of the company's Class A Common Stock. The transaction, which took place on May 16, 2024, fetched a price of $23.85 per share, amounting to a total value of $35,775.

The sale was executed automatically under a Rule 10b5-1 trading plan, which was adopted by Overpeck on May 26, 2023. Rule 10b5-1 trading plans allow corporate insiders to set up a predetermined plan to sell company stocks, enabling them to avoid accusations of insider trading by selling at times when they might possess non-public information.

In addition to the sale, the filing also disclosed that shares were withheld by Doximity to satisfy tax withholding obligations related to the vesting of restricted stock units granted to Overpeck. The shares withheld on May 15, 2024, totaled 2,862 at a price of $23.51 each, leading to a total transaction value of $67,285. This withholding is a standard procedure mandated by elections made by the issuer and is not considered a discretionary trade by the reporting person.

Following these transactions, Overpeck's direct holdings in Doximity stand at 108,609 shares of Class A Common Stock. The recent sales and withholdings provide a glimpse into the executive's trading activities and changes in their stake in the company.

Investors and market watchers often scrutinize insider trades as they can provide insights into an executive's view of the company's future prospects. However, it is important to note that such transactions do not necessarily indicate a change in company fundamentals or future performance.

Doximity, headquartered in San Francisco, operates within the technology sector, providing computer programming services. The company has established itself as a leading platform for medical professionals to connect and collaborate online.

InvestingPro Insights

Following the insider trading activity at Doximity, Inc. (NYSE:DOCS), investors may be curious about the company's financial health and market performance. According to InvestingPro data, Doximity boasts a market capitalization of approximately $5.26 billion USD and maintains a high gross profit margin of 89.34% for the last twelve months as of Q4 2024. This impressive margin underscores the company's efficiency in its operations and its ability to retain a significant portion of revenue after accounting for the cost of goods sold.

Moreover, Doximity's share price has experienced a notable one-week total return of 19.94% as of the same period, reflecting a short-term positive movement in the market. However, the year-to-date (YTD) price total return stands at a slight decrease of -0.04%, indicating near-term fluctuations in the stock's performance.

In terms of valuation, Doximity is trading at a price-to-earnings (P/E) ratio of 35.91, suggesting that investors are willing to pay a premium for the company's earnings. This could be attributed to the confidence in the company's future growth prospects or its current market position. An InvestingPro Tip highlights that Doximity holds more cash than debt on its balance sheet, which is a strong indicator of financial stability and may reassure investors about the company's ability to manage its finances effectively.

For those interested in further analysis and tips, InvestingPro offers additional insights, including the fact that management has been aggressively buying back shares, which could be a signal of confidence in the company's valuation and future. There are over 10 additional InvestingPro Tips available for Doximity, which can be accessed by subscribing to the service. Don't forget to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, providing valuable information for making informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.